BRD2 and endometriosis: Three pre-menopausal patients with refractory endometriosis and chronic pelvic pain were treated with anastrozole for a 6-month period (while one was treated with letrozole) after which pelvic pain, serum estradiol, FSH and LH were assessed in addition to bone density changes.